ESC 365 - JNK-2 silencing with focally acting peptide-siRNA nanostructures modulates plaque inflammation in atherosclerotic mice

ESC Premium Access

JNK-2 silencing with focally acting peptide-siRNA nanostructures modulates plaque inflammation in atherosclerotic mice

Session: Inflammation and vascular disease

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Associate Professor H. Pan (Saint Louis, US)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Associate Professor Hua Pan

WASHINGTON UNIVERSITY MEDICAL CENTER, Saint Louis (United States of America)

0 follower

4 more presentations in this session

Eosinophils promote arterial thrombosis through release of major basic protein

Speaker: Doctor J. Novotny (Munich, DE)

Nanoparticle-mediated simultaneous targeting of mitochondria and inflammatory monocytes protects the brain from ischemia-reperfusion injury in mice

Speaker: Doctor A. Okahara (Fukuoka, JP)

Inflammatory cytokine oncostatin M induces endothelial activation in vitro and in APOE*3Leiden.CETP mice

Speaker: Ms D. Van Keulen (Utrecht, NL)

PI3-kinase delta protects against atherosclerosis progression by controlling regulatory T-cell homeostasis and function

Speaker: Doctor M. Zierden (Cologne, DE)

Access the full session

Inflammation and vascular disease

Speakers: Associate Professor H. Pan, Doctor J. Novotny, Doctor A. Okahara, Ms D. Van Keulen, Doctor M. Zierden

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by